Fundraising FoxAPERTURE Venture Partners
Venture capitalNew York · Seed–Series C · 4 people tracked
Also known as APERTURE MANAGEMENT LLC
Find your way into APERTURE Venture Partners
Each arrow is one introduction. Sign up to fill in the first one.
Ask Shane Kreidel to introduce you to Tony Natale
You →Shane · together at XII Medical →Tony
Ask Jamie Chen to introduce you to Eric H. Sillman
You →Jamie · together at Xlumena →Eric
Ask Sam Okafor to introduce you to Thomas P. Cooper
You →Sam · together at Aperture Venture Capital →Thomas
Sign up to find every way you can get introduced to APERTURE Venture Partners
- Your email: who you already know at APERTURE Venture Partners, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the APERTURE Venture Partners team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Aperture Venture Partners focuses on healthcare investing, partnering with entrepreneurs to build innovative companies across medical devices, pharmaceuticals, healthcare IT and services, and diagnostics. The firm emphasizes its partners' deep industry knowledge and track record of helping companies reach their potential, pointing to several portfolio companies that have surpassed $1 billion valuations.
Source: firm website, verified Sep 29, 2026.
Team · 4 people
from the firm's website & public directoriesWhat they invest in
from 30 of 44 portfolio companiesHealthtech ×27Medical Devices ×22Biotech ×13Hardware ×7Digital Health ×6Deep Tech ×2SaaS ×2Developer Tools ×1
HQs:United States×25Israel×1
Who they back
founder profiles across 13 portfolio companiesFounding team size:solo founder×82 founders×23 founders×24+ founders×1
Investments · 44 tracked
founders shown can be your intro pathBy year:2025 · 22024 · 22022 · 22020 · 12019 · 22018 · 12016 · 32015 · 12011 · 216 dated
Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases.
BiotechHealthtechMedical DevicesWayne, US
Neal Walker(Executive Officer, Director)Kamil Ali-Jackson(Executive Officer)Stuart D. Shanler(Executive Officer)inJoseph Monahan(Executive Officer)inHugh Davis(Executive Officer, Director)inJames Loerop(Executive Officer)
Co-investorsAisling CapitalF-Prime CapitalForesite CapitalRA CapitalSofinnova VenturesSofinnova Venture Partners+1 more
Collegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions.
BiotechCanton, US
Michael Heffernan(Executive Officer, Director)inPaul Brannelly(Executive Officer)inVikram Karnani(President and Chief Executive Officer, and Director)in
BoardEran Nadav(Director)John Freund(Director)Patrick Heron(Director)in
Co-investorsEcoR1 CapitalFrazier Life SciencesLongitude CapitalBoston Millennia PartnersRA Capital
Shoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis.
HardwareHealthtechMedical DevicesNorthern California, US
Robert Ball(CEO & Executive Chairman)Matthew Ahearn(Chief Operating Officer)inJeff Points(Executive Officer)inDavid Blue(Executive Officer)inDon Running(Manager and Chief Executive Officer)Jeff Ondrla(Chief Technology Officer)
Co-investorsAlumni VenturesArboretum VenturesGenesis Innovation GroupGlobal BrainInvest MichiganLightstone Ventures+3 more
Tarsus is a biopharmaceutical company focused on developing and delivering medicines that target the root cause of serious diseases with high unmet need, including eye conditions.
BiotechHealthtechMedical Devices
Bobak Azamian, MD, PhD(Founder)inBobak Azamian(President and Chief Executive Officer)inJeffrey Farrow(Chief Financial Officer and Chief Strategy Officer)Seshadri Neervannan(Chief Operating Officer)Aziz Mottiwala(Chief Commercial Officer)inDianne Whitfield(Chief Human Resources Officer)in
Co-investorsFlying L PartnersFrazier Life SciencesVisionary VenturesVivo CapitalBain Capital Life SciencesRTW Investments L.P.+1 more
Trevi Therapeutics is a clinical-stage biopharmaceutical company developing Haduvio (oral nalbuphine ER), an investigational therapy for chronic cough that targets the central and peripheral cough reflex arc.
BiotechHealthtechNew Haven, US
Thomas Sciascia(Executive Officer)Jennifer Good(Co-Founder, President and CEO)inThomas Sciascia, M.D.(Co-Founder, Chief Scientific Officer)Lisa Delfini(Executive Officer)inWilliam Forbes(Executive Officer)inMichael Heffernan(Director)in
Co-investorsFrazier Life SciencesNew Enterprise Associates (NEA)Pivotal Life SciencesViking GlobalOmega Funds
VS3 Medical is a medical device company developing the VS3 Medical Stent System, an investigational neurovascular implant designed to treat symptomatic venous sinus stenosis within the dural venous sinus anatomy.
HardwareHealthtechMedical Devices
Co-investorsGilde HealthcareUS Venture Partners
BiotechHealthtechMedical DevicesWaltham, US
David F. Muller(Executive Officer, Director)inBrian J. Roberts(Executive Officer)inRhonda J. Bracey(Executive Officer)in
BoardJason Hong(Director)Jeff Dykan(Director)inAnthony Natale(Director)in
Co-investorsLAVLilly Asia VenturesSCP Vitalife PartnersThird Point VenturesAbingworthBorealis Ventures+4 more
Axonics Modulation, now part of Boston Scientific, develops medical devices in the field of neuromodulation therapies for patients.
HealthtechMedical Devices
Raymond Cohenin
Co-investorsLongitude CapitalGilde Healthcare
BardyDx develops the Carnation Ambulatory Monitor (CAM), a lightweight cardiac patch monitor designed for extended-wear ambulatory ECG monitoring that emphasizes P-wave signal clarity.
Digital HealthHealthtechMedical DevicesSeattle, US
Gust H. Bardy(Executive Officer, Director, Promoter)Mark Querry(Executive Officer)Kevin Nelson, III(Executive Officer)Rik Vandevenne(Director)Alan Levy(Director)Mark Handfelt(Executive Officer, Promoter)
Co-investorsAphelion CapitalAscension VenturesLumira VenturesRC CapitalRex Health VenturesSV Health Investors+2 more
Biohaven is a biopharmaceutical company that discovers, develops, and commercializes treatments across immunology, obesity, neuroscience, and oncology, targeting rare and common diseases with limited treatment options.
BiotechHealthtech
Vlad Coric(Chairman & Chief Executive Officer)in
Co-investorsAisling CapitalConnecticut InnovationsOUP (Osage University Partners)HBM Healthcare InvestmentsOrbiMed
Cardiac Dimensions develops medical technology to treat heart failure caused by functional mitral regurgitation (FMR), aiming to address underlying causes rather than symptoms.
BiotechHealthtechMedical DevicesKirkland, US
Frederick A. Stewart(Executive Officer, Director)Rick Wypych(Executive Officer)in
BoardKurt Wheeler(Director)Nathan Every(Director)Douglas C. Fisher(Director)Gerry Brunk(Director)in
Co-investorsLumira VenturesRedbus VenturesAlly Bridge GroupClaret Capital PartnersJefferiesM.H. Carnegie & Co.
HealthtechEmeryville, US
Bill Malecki(Executive Officer)Daniel Burnett(Director)Ulric Cote(Executive Officer, Director)
BoardDr. Jason Hong(Director)Anthony Natale(Director)inCarter Mayer(Director)
Co-investorsGreen Park & Golf VenturesScientific Health DevelopmentThird Point VenturesLongwood FundVHM
Cortica provides in-home, in-clinic, and telehealth neurological therapies for children with autism and developmental differences, integrating neurological, biomedical, behavioral, speech-language, and sensorimotor treatments.
Digital HealthHealthtechMedical DevicesSan Diego, US
Dr. Suzanne Goh(Founder)Neil Hattangadi(Executive Officer, Director)inBriana Elvaiah(Executive Officer)in
BoardRyan Drant(Director)inStephen Anastos(Director)Justin Brock(Director)in
Co-investors.406 VenturesAIFCVS Health VenturesEcho Health VenturesLongitude CapitalOptum Ventures+5 more
Devoro Medical developed the WOLF Thrombectomy Platform, a non-console, lytic-free medical device that uses finger-like prongs to capture and remove blood clots (thrombi) from the arterial and venous systems.
HardwareHealthtechMedical DevicesFremont, US
BoardErik Engelson(Director)Michael Wallace(Executive Officer, Director)Skott Greenhalgh(Director)
Co-investorsShangBay Capital LLCNorwest Venture Partners
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Harry Rowland(Executive Officer, Director)inAnthony I Nunez(Executive Officer, Director)inAnthony A. Nunez(Executive Officer, Director)inAnthony Nunez(Founder)in
BoardJonathan Jonas(Director)Raymond S. Barrett, Jr.(Director)
Co-investorsBioventures InvestorsJumpstart VenturesLumira VenturesOSF VenturesSeroba Life SciencesSV Health Investors+1 more
Designs and manufactures instruments and devices for sinus surgery; acquired by Smith & Nephew in 2013.
Co-investorsTargeted Technology Funds
Inspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective.
Digital HealthHealthtechMedical DevicesGolden Valley, US
Tim Herbert(Founder)in
BoardMudit Jain(Director)Joyce Erony(Director)inDana Mead(Director)Chau Khuong(Director)inCasey Tansey(Director)
Co-investorsAmzak HealthUS Venture PartnersOrbiMed
Developed a robotic surgical arm for knee and hip arthroplasty; acquired by Stryker for $1.65B in 2013.
Co-investorsLumira VenturesMontreux Equity Partners
Miach Orthopaedics develops implants that help the body restore its own connective tissue, with an initial focus on treating ACL tears.
HealthtechMedical DevicesWestborough, US
Martha Murray(Founder)inChris Joyce(Executive Officer)inPatrick McBrayer(Executive Officer, Director)inSean Sansiveri(Director)Pieter Wolters(Director)
BoardMarc-Andre Marcotte(Director)
Co-investorsAmzak HealthEndeavour VisionSV Health Investors
Nalu Medical develops a non-integrated neurostimulation system that uses electrical impulses to interrupt pain signals for patients with intractable chronic nerve pain.
HardwareHealthtechMedical DevicesCarlsbad, US
Earl Fender(President & CEO)inLee Hartley(Executive Officer)inAllen Meacham(Executive Officer)inBick Sellers(Executive Officer)inThomas A. West(Executive Officer, Director)inJeffrey Swiecki(Executive Officer)
Co-investorsB Capital GroupB4 CapitalDecheng CapitalEndeavour VisionLongitude CapitalMVM Life Science Partners+3 more
.jpeg){kind=logo}
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)in
BoardJoyce Erony(Director)inWilliam Harrington(Director)in
Co-investorsAmzak HealthCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart VenturesRiverVest Venture Partners+6 more
NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model.
Deep TechHealthtechMedical Devices
Co-investorsTreo Ventures, LlcAmzak HealthNorwest Venture PartnersOSF VenturesU.S. Venture Partners
Developer ToolsE-commerceSaaS
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)inBrad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)in
Co-investorsAmzak HealthBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF VenturesSeroba Life Sciences+3 more
SoundBlade Medical develops handheld histotripsy technology for non-invasive surgery, using focused ultrasound to treat tissue with precision.
HardwareHealthtechMedical Devices
Jeremy Brown(Co-Founder & CTO)inMatt Mallay(Co-Founder & Sr. Dir. R&D)inAndre Bezanson(Co-Founder & Dir. R&D)inEli Vlaisavljevich(Co-Founder)inRick Balys(Co-Founder)inNeil Barman(Chief Executive Officer)in
Co-investorsAmzak HealthLumira VenturesInvest Nova Scotia
Menlo Park, US
Duke Rohlen(Chief Executive Officer)
BoardCamille Samuels(Director)Anthony Natale(Director)inReed Gaither(Director)Aftab Kherani(Director)Ron Kuppersmith(Director)
Co-investorsAisling CapitalCorrelation VenturesVenrockHealthQuest CapitalVenrock AssociatesWestern Technology Investment
HealthtechLexington, US
Michael Cima, Ph.D.(Director)Rahul Dhanda(Senior Vice President, Corporate Development)inJohn McDonough(Chief Executive Officer)inTom Lowery, Ph.D.(Chief Scientific Officer)Michael Gibbs, Esq.(Vice President and General Counsel)Joanne Spadoro, Ph.D.(Chief Operating Officer)in
Co-investorsAisling CapitalArcus VenturesFlagship VenturesFlybridge Capital PartnersJohnson & Johnson Innovation – JJDCPolaris Partners+1 more
uLab Systems builds digital orthodontics tools, including software (uDesign, uAssist) and uSmile clear aligners manufactured in the USA, for dental professionals and orthodontic practices.
BiotechDigital HealthHealthtechMedical DevicesSaaSMemphis, US
AmirAli Talasaz(Director)Mark Foley(Director)David Thrower(Executive Officer)Tim Dumore(Director)Rita O'Connor(Director)Robert Doty(Executive Officer)
Co-investors7 Gate VenturesCivilization Ventures Management, LlcTachles VC
V-Wave Medical develops a percutaneous implantable shunt device for treating chronic heart failure patients.
BiotechHealthtechMedical DevicesIsrael, IL
Co-investorsBRM CapitalPontifax Venture CapitalTriventures
Venus develops non-invasive, energy-based medical aesthetic devices for body, face, skin, and hair treatments, integrating robotics, AI, and IoT technologies.
BiotechHardwareHealthtechMedical DevicesToronto, US
Domenic Serafino(Executive Officer, Director)inKirk Gunhus(Executive Officer)inRoss Portaro(Executive Officer)inAnna Georgiadis(Executive Officer)inMelissa Kang(Executive Officer)inMichael Mandarello(Executive Officer)in
Co-investorsEssex Woodlands Healthcare PartnersLongitude CapitalClarus VenturesHealthQuest Capital
XII Medical develops neuromodulation therapies for treating obstructive sleep apnea, focusing on simplifying treatment options and improving patient outcomes.
Deep TechDigital HealthHealthtechMedical DevicesUnion City, US
Garrett Schwab(Chief Executive Officer)inShane Kreidel(Secretary and Chief Financial Officer)inZachary Eisen(Director)
BoardDuke Rohlen(Director)inJD Friedland(Director)Saoussen Ben Halima(Director)
Co-investorsBroadview VenturesCincyTechIntuitive VenturesJobsOhio VenturesAjax HealthOmega Funds
HealthtechMountain View, US
Kenneth Binmoeller, M.D.(Executive Officer, Director)Greg Patterson(Executive Officer, Director)
BoardA. Barr Dolan(Director)Eric Sillman(Director)Anthony Natale, M.D.(Director)Avi Kometz(Director)
Co-investorsATEL VenturesThird Point VenturesAscent Biomedical VenturesDeerfield Management CompanyThird PointWestern Technology Investment
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Cameron HealthCardiocore LabCeptaris TherapeuticsCeption TherapeuticsConcerroConor MedsystemsInterlace Medical, Inc.OtonomyTherOxTransMolecularVerix Health
Exits · 9
5 IPOs · 4 acquisitions · showing 8Aclaris TherapeuticsNASDAQ: ACRSCollegium PharmaceuticalNASDAQ: COLLShoulder InnovationsNYSE: SITarsus PharmaceuticalsNASDAQ: TARSTrevi TherapeuticsNASDAQ: TRVIAvedroacq. by GlaukosConor Medsystemsacq. by Johnson & JohnsonEntrigue Surgicalacq. by Smith+Nephew
Portfolio news
latest coverage across their companiesTrevi Therapeutics · simplywall.st · Aug 1, 2026
Shoulder Innovations · prnewswire.com · May 13, 2026
Nalu · trysignalbase.com · Mar 25, 2026
Neuros Medical · finsmes.com · Jul 9, 2025
Frequently asked questions
- How many investments has APERTURE Venture Partners made?
- APERTURE Venture Partners has 44 tracked investments, 9 of which have exited, including 3 dated in the last 24 months.
- What stage does APERTURE Venture Partners invest at?
- APERTURE Venture Partners invests at the Seed, Series A, Series B, Series C stages.
- What is APERTURE Venture Partners's typical check size?
- APERTURE Venture Partners typically writes checks of $1M – $5M.
- What sectors does APERTURE Venture Partners focus on?
- APERTURE Venture Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is APERTURE Venture Partners located?
- APERTURE Venture Partners is headquartered in New York, US.
- Who does APERTURE Venture Partners co-invest with?
- APERTURE Venture Partners most often shares deals with Longitude Capital, Lumira Ventures, Aisling Capital, among 83 tracked co-investors.
Media · Podcasts & interviews
featuring the teamTony Natale, MD, Aperture Venture Partners, Intro: 2nd Annual PE/VC Conference
CFA Society New York · Tony Natale
Co-investors · 5
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
OUP (Osage University Partners) is a venture firm that invests in science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.
Deerfield Management is a healthcare-focused investment firm that supports companies across the healthcare ecosystem through flexible funding, market intelligence, and philanthropic initiatives.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Signet Healthcare Partners provides growth capital to commercial-stage healthcare companies worldwide, focusing on pharmaceutical and medical device businesses that are revenue-generating or preparing for commercial launch.
Firms observed investing alongside APERTURE Venture Partners, from public investor directories. Shared companies are the overlap with APERTURE Venture Partners's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
Vesalius Biocapital is a European life sciences venture capital investor focused on later-stage companies in drug development, medical devices and diagnostics, and eHealth/mHealth. Its active fund, Vesalius Biocapital III, closed in May 2019 with €120 million in commitments.